Aelis Farma SA (EPA:AELIS)
France · Delayed Price · Currency is EUR 1.100
-0.014 (-1.26%)
Jun 12, 2026, 5:35 PM CET
Aelis Farma Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | - | 2.68 | 9.05 | 3.81 | 9.08 |
Other Revenue | 2.08 | 2.88 | 3.3 | 4.56 | 1.69 |
| 2.08 | 5.56 | 12.36 | 8.36 | 10.76 | |
Revenue Growth (YoY) | -62.53% | -54.99% | 47.75% | -22.28% | 846.53% |
Gross Profit | 2.08 | 5.56 | 12.36 | 8.36 | 10.76 |
Selling, General & Admin | 2.52 | 3.36 | 2.61 | 3.1 | 1.34 |
Research & Development | 5.77 | 9.94 | 16.21 | 13.79 | 6.87 |
Operating Expenses | 8.29 | 13.3 | 18.82 | 16.89 | 8.21 |
Operating Income | -6.2 | -7.74 | -6.46 | -8.53 | 2.55 |
Interest Expense | -0.29 | -0.23 | -0.16 | -0.11 | -0.14 |
Interest & Investment Income | - | - | 0.42 | 0.05 | 0 |
Currency Exchange Gain (Loss) | -0.15 | 0.05 | 1.09 | -0.01 | 0.72 |
Other Non Operating Income (Expenses) | 0.21 | 0.49 | 0.03 | -5.69 | -1.38 |
EBT Excluding Unusual Items | -6.43 | -7.42 | -5.08 | -14.29 | 1.76 |
Gain (Loss) on Sale of Investments | 0 | -0.03 | - | - | - |
Pretax Income | -6.43 | -7.45 | -5.08 | -14.29 | 1.76 |
Income Tax Expense | 0.01 | 0.01 | 0 | 0 | 1.19 |
Net Income | -6.43 | -7.46 | -5.08 | -14.29 | 0.57 |
Net Income to Common | -6.43 | -7.46 | -5.08 | -14.29 | 0.57 |
Shares Outstanding (Basic) | 14 | 13 | 13 | 12 | 10 |
Shares Outstanding (Diluted) | 14 | 13 | 13 | 12 | 10 |
Shares Change (YoY) | 1.96% | 4.22% | 8.94% | 23.49% | 0.01% |
EPS (Basic) | -0.47 | -0.55 | -0.39 | -1.21 | 0.06 |
EPS (Diluted) | -0.47 | -0.55 | -0.39 | -1.21 | 0.06 |
Free Cash Flow | -5.36 | -12.02 | -13.05 | -13.09 | 18.76 |
Free Cash Flow Per Share | -0.39 | -0.89 | -1.01 | -1.10 | 1.96 |
Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
Operating Margin | -297.60% | -139.12% | -52.30% | -101.92% | 23.71% |
Profit Margin | -308.73% | -134.05% | -41.09% | -170.83% | 5.33% |
Free Cash Flow Margin | -257.05% | -216.13% | -105.58% | -156.48% | 174.29% |
EBITDA | -6.11 | -7.65 | -6.4 | -8.48 | 2.57 |
EBITDA Margin | -293.14% | -137.59% | -51.80% | -101.35% | 23.85% |
D&A For EBITDA | 0.09 | 0.09 | 0.06 | 0.05 | 0.02 |
EBIT | -6.2 | -7.74 | -6.46 | -8.53 | 2.55 |
EBIT Margin | -297.60% | -139.12% | -52.30% | -101.92% | 23.71% |
Effective Tax Rate | - | - | - | - | 67.37% |
Revenue as Reported | 2.08 | 5.56 | 12.36 | 8.36 | 10.76 |